Skip to main content

Table 2 Identification of cell surface markers distinguishing myofibroblasts and fibroblasts

From: Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences

Gene ΔCt of linnegof saline-treated lungs ΔCt of linnegof bleomycin-injured lungs of day 12 ΔΔCt Fold change (Bleo/saline)
CD49e 9.7 6.8 −2.9 5.50*
CD44 8.4 7.0 −1.4 2.28*
CD29 7.9 7.1 −0.8 1.60
CD140b 8.8 8.8 0.0 1.00
CD147 8.8 8.9 0.1 0.94
CD120a 6.8 7.0 0.2 0.89
CD140a 7.5 8.0 0.5 0.75
CD107a 8.2 8.8 0.6 0.70
CD47 8.4 9.2 0.8 0.62*
CD81 8.0 9.0 1.0 0.56*
CD119 7.8 8.9 1.1 0.52*
CD54 7.7 9.0 1.3 0.47*
Sca-1 6.6 8.0 1.4 0.44*
  1. ΔCt = Ct of a gene of the sample minus Ct of 18 s rRNA of the sample. ΔΔCt = ΔCt of linneg of bleomycin-injured lungs at day 12 minus ΔCt of linneg of saline-treated lungs. Calculation for fold change in gene levels between bleomycin-injured lungs at day 12 and saline-treated lungs (bleomycin/saline) is described in Methods. QRT-PCR was performed in triplicate using three independently prepared RNA samples. Results represent the mean of three experiments. *, P < 0.05.